Markets · 1 sources covering this

Insilico Sees Rising Revenue From Deals With AI Firms

Alex Zhavoronkov, Founder & CEO at Insilico Medicine, discusses the AI-drug discovery firm's earnings and business outlook exclusively on "Bloomberg: The China Show." (Source: Bloomberg)

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·1h ago
Insilico Sees Rising Revenue From Deals With AI Firms
Alex Zhavoronkov, Founder & CEO at Insilico Medicine, discusses the AI-drug discovery firm's earnings and business outlook exclusively on "Bloomberg: The China Show." (Source: Bloomberg)
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/3e5c266073906411d251ae0bf169d870ab69f0f9"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Insilico Sees Rising Revenue From Deals With AI Firms"></iframe>

Insilico Sees Rising Revenue From Deals With AI Firms

How 1 sources are covering this

Insilico Sees Rising Revenue From Deals With AI Firms

More from Markets

FTSE 100 Live: UK Stocks to Miss Out on Nvidia-Fueled Rally

Swats: Saudi Derivatives Push Targets Global Investors

Indonesia’s Rupiah, Bonds Edge Lower as Investors Eye Protest in Jakarta

China’s Fujia Is Said to Consider Sale of Hexie Health Insurance

Reader

Trust & legal

Across the network